Lipopolysaccharide-induced tumor necrosis factor-alpha production pathway (LPS-TNFα pathway)

The Lipopolysaccharide (LPS)-induced tumor necrosis factor-alpha (TNF-α) production pathway in RAW 264.7 macrophages is a canonical model for studying innate immunity and inflammatory signaling (Raschke et al., 1978). This pathway is initiated when LPS, an endotoxin from Gram-negative bacteria, binds to the Toll-like receptor 4 (TLR4)/MD-2 complex on the macrophage cell surface (Poltorak et al., 1998). This binding event triggers a complex intracellular signaling cascade involving adaptor proteins such as MyD88 and TRIF, which activate downstream kinases including IκB kinase (IKK) and Mitogen-Activated Protein Kinases (MAPKs) (Medzhitov et al., 1997). These kinases facilitate the activation and nuclear translocation of the transcription factor Nuclear Factor-kappa B (NF-κB), which binds to the promoter region of the TNF-α gene to induce its transcription (Aggarwal, 2003). TNF-α is a potent pro-inflammatory cytokine that plays a central role in the pathogenesis of various inflammatory and autoimmune diseases, including sepsis, rheumatoid arthritis, and inflammatory bowel disease (Tracey et al., 1987). Therapeutic strategies targeting this pathway include the use of TLR4 antagonists like TAK-242, NF-κB inhibitors, and monoclonal antibodies such as Infliximab that neutralize secreted TNF-α (Matsunaga et al., 2011). The RAW 264.7 cell line is frequently utilized in pharmacological research to evaluate the efficacy of novel anti-inflammatory compounds by measuring their ability to suppress TNF-α production following LPS stimulation (Taciak et al., 2018). Dysregulation of this pathway is a hallmark of systemic inflammatory response syndrome and chronic inflammatory conditions.

Other names

LPS-induced inflammatory signalingTLR4-mediated TNF-alpha expressionEndotoxin-induced cytokine cascadeLPS/TLR4/NF-κB signaling axis

Inhibition of TLR4 receptor activation, suppression of NF-κB nuclear translocation, blockade of MAPK phosphorylation, or direct neutralization of the secreted TNF-alpha cytokine product.